Drugs / QH103 Cell Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06056752 | Sep 2023 → Jul 2025 | B-cell acute lymphoblastic leukemia | Anhui Provincial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QH103 Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06056752 ↗ |
| Modality | Cell therapy | “CD19 CAR-γδT Cell Injection” NCT06056752 ↗ |